Discussion on opportunities for industry through EDCTP
22 October 2015 | Webinar (By invitation only)
The European & Developing Countries Clinical Trials Partnership (EDCTP, www.edctp.org) is a public-public partnership of 14 European and 14 sub-Saharan African countries supported by the European Union. Its mission is to accelerate the clinical development of effective, safe, accessible, suitable and affordable medical interventions for poverty-related diseases, in partnership with sub-Saharan Africa. To achieve this general objective EDCTP will strengthen international research collaboration with sub-Saharan African and will also actively seek to involve the private sector.
On the basis of competitive public calls for proposals, it funds the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as neglected (or emergent) infectious diseases including Ebola. All clinical trials from phase I-IV are funded (with a focus on phase II and III), including health systems optimisation research and capacity building (such as fellowships and support of research ethics review and regulatory capacity in sub-Saharan Africa).
The second EDCTP programme (2014-2024) is executed by the EDCTP Association as part of the European Framework Programme Horizon 2020. The European Union will contribute up to € 683 million for the 10-year programme, provided this is matched by contributions from the European members of the Association. To date, EDCTP2 calls for proposals have covered topics on diagnostics, treatment, large strategic trials and research capacity development, while future calls are expected to address additional gaps in treatment and prevention of HIV/AIDS and other poverty-related diseases in sub-Saharan Africa.
Webinar with Industry Liaison Forum
EDCTP Secretariat, The Hague, The Netherlands